CCL13 and human diseases

CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many immune cells. Despite extensive research into its function in numerous disorders, a thorough analysis of CCL13 is not yet accessible. The role of CCL13 in human disorders and existing CCL13-focused therapies are outlined in this study. The function of CCL13 in rheumatic diseases, skin conditions, and cancer is comparatively well-established, and some studies also suggest that it may be involved in ocular disorders, orthopedic conditions, nasal polyps, and obesity. We also give an overview of research that found very little evidence of CCL13 in HIV, nephritis, and multiple sclerosis. Even though CCL13-mediated inflammation is frequently linked to disease pathogenesis, it’s fascinating to note that in some conditions, like primary biliary cholangitis (PBC) and suicide, it might even act as a preventative measure.

[1]  Xiao Li,et al.  Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer , 2022, Frontiers in Oncology.

[2]  M. Lebwohl,et al.  Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata , 2022, Allergy.

[3]  Qianghu Wang,et al.  Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma. , 2022, Cancer letters.

[4]  Zhaoyu Lin,et al.  Tumor-Associated Macrophages Promote Metastasis of Oral Squamous Cell Carcinoma via CCL13 Regulated by Stress Granule , 2022, Cancers.

[5]  D. Tang,et al.  Current Understanding of Asthma Pathogenesis and Biomarkers , 2022, Cells.

[6]  M. Gustafsson,et al.  Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy , 2022, Frontiers in Immunology.

[7]  S. Madhi,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis , 2022, The Lancet.

[8]  A. Kamali,et al.  Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A , 2022, IJID Regions.

[9]  Liying Ren,et al.  Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease , 2022, Frontiers in Immunology.

[10]  M. Sokolowska,et al.  Understanding uncontrolled severe allergic asthma by integration of omic and clinical data , 2021, Allergy.

[11]  C. Delacourt,et al.  A Comprehensive Analysis of Immune Constituents in Blood and Bronchoalveolar Lavage Allows Identification of an Immune Signature of Severe Asthma in Children , 2021, Frontiers in Immunology.

[12]  Lei Wu,et al.  Inflammation and tumor progression: signaling pathways and targeted intervention , 2021, Signal Transduction and Targeted Therapy.

[13]  P. Schmid‐Grendelmeier,et al.  Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients. , 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  R. Sadreyev,et al.  Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-Infection and Nonalcoholic Fatty Liver Disease. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Jinhua Huang,et al.  CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity , 2021, Experimental dermatology.

[16]  C. Bollard,et al.  Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma , 2020, Cancers.

[17]  D. Sin,et al.  Abundance of Non-Polarized Lung Macrophages with Poor Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD) , 2020, Biomedicines.

[18]  Yan Liang,et al.  Characteristics of serum chemokine profile in primary biliary cholangitis. , 2020, Cytokine.

[19]  I. Baranowska-Bosiacka,et al.  Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review , 2020, International journal of molecular sciences.

[20]  Wei Tang,et al.  Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas , 2020, BioMed research international.

[21]  G. Singer,et al.  Cross-sectional study of blood biomarkers of patients with moderate-to-severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. , 2020, Journal of the American Academy of Dermatology.

[22]  M. Mildner,et al.  Single-cell transcriptomics combined with interstitial fluid proteomics defines cell-type-specific immune regulation in atopic dermatitis. , 2020, The Journal of allergy and clinical immunology.

[23]  O. Viklicky,et al.  Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category , 2020, Frontiers in Immunology.

[24]  Xiaomei Wang,et al.  Enhancement of Chemokine mRNA Expression by Toll-Like Receptor 2 Stimulation in Human Peripheral Blood Mononuclear Cells of Patients with Atopic Dermatitis , 2020, BioMed research international.

[25]  C. Billington,et al.  Pro-Inflammatory Effects in ex vivo Human Lung Tissue of Respirable Smoke Extracts from Indoor Cooking in Nepal. , 2020, Annals of the American Thoracic Society.

[26]  A. Gelber,et al.  Osteoarthritis , 2020, Annals of Internal Medicine.

[27]  W. Xia,et al.  The role of Th1/Th2 cell chemokine expression in hypertrophic scar , 2020, International wound journal.

[28]  C. Fullerton,et al.  Potential chemokine biomarkers associated with PTSD onset, risk and resilience as well as stress responses in US military service members , 2020, Translational Psychiatry.

[29]  W. Xia,et al.  Imiquimod regulating Th1 and Th2 cell‐related chemokines to inhibit scar hyperplasia , 2019, International wound journal.

[30]  Peter Butterworth,et al.  The association between mental disorders and suicide: A systematic review and meta-analysis of record linkage studies. , 2019, Journal of affective disorders.

[31]  Honghua Yu,et al.  Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion , 2019, Molecular vision.

[32]  D. Kelly,et al.  Osteoarthritis-associated basic calcium phosphate crystals alter immune cell metabolism and promote M1 macrophage polarization. , 2019, Osteoarthritis and cartilage.

[33]  A. Paller,et al.  The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease. , 2019, Journal of the American Academy of Dermatology.

[34]  L. Denis,et al.  Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis. , 2019, The Journal of allergy and clinical immunology.

[35]  H. Otu,et al.  Translating transcription: proteomics in chronic rhinosinusitis with nasal polyps reveals significant discordance with messenger RNA expression , 2019, International forum of allergy & rhinology.

[36]  Ning Zhang,et al.  Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. , 2019, The Journal of allergy and clinical immunology.

[37]  J. Glenn,et al.  The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection , 2019, Journal of gastroenterology and hepatology.

[38]  R. Shattock,et al.  Enhanced in vivo mucosal interferon and chemokine responses to a single stranded RNA analogue (R848) in participants with asthma , 2019, Allergy and immunology.

[39]  Dave Singh,et al.  The pathology of small airways disease in COPD: historical aspects and future directions , 2019, Respiratory Research.

[40]  U. Landegren,et al.  Protein profiling of fine‐needle aspirates reveals subtype‐associated immune signatures and involvement of chemokines in breast cancer , 2019, Molecular oncology.

[41]  R. Rieben,et al.  Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment , 2018, Acta ophthalmologica.

[42]  G. Opdenakker,et al.  The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA‐B27‐associated uveitis , 2018, Acta ophthalmologica.

[43]  I. Pavord,et al.  Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles , 2018, Journal of Allergy and Clinical Immunology.

[44]  Yongjian Xu,et al.  Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study , 2018, The Lancet.

[45]  Charlotte M. Höög,et al.  Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study , 2017, International journal of molecular sciences.

[46]  E. Cunningham,et al.  Clinical Spectrum of HLA-B27-associated Ocular Inflammation , 2017, Ocular immunology and inflammation.

[47]  K. Nakagome,et al.  Eosinophil transendothelial migration induced by the bronchoalveolar lavage fluid of acute eosinophilic pneumonia , 2017, Respirology.

[48]  G. Han The Changing Landscape of Alopecia Areata: An Introduction , 2017, Advances in Therapy.

[49]  J. Margolick,et al.  Multiplex assay reliability and long‐term intra‐individual variation of serologic inflammatory biomarkers , 2017, Cytokine.

[50]  D. Jacobowitz,et al.  The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder , 2017, Translational Psychiatry.

[51]  C. Pedersen,et al.  Plasma cytokines eotaxin, MIP‐1α, MCP‐4, and vascular endothelial growth factor in acute lower respiratory tract infection , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[52]  R. Schleimer Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. , 2017, Annual review of pathology.

[53]  A. Easton,et al.  Human Brain Chemokine and Cytokine Expression in Sepsis: A Report of Three Cases , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[54]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[55]  Y. Toiyama,et al.  Elevated serum concentration of monocyte chemotactic protein 4 (MCP‐4) as a novel non‐invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer , 2016, Journal of surgical oncology.

[56]  Ashley C. Mays,et al.  Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma. , 2016, Anticancer research.

[57]  D. Xue,et al.  HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation. , 2016, Molecular medicine reports.

[58]  G. Lupattelli,et al.  Circulating Levels of the Adipokines Monocyte Chemotactic Protein-4 (MCP-4), Macrophage Inflammatory Protein-1β (MIP-1β), and Eotaxin-3 in Severe Obesity and Following Bariatric Surgery , 2016, Hormone and Metabolic Research.

[59]  G. Kim,et al.  Inhibition of inflammatory reactions in 2,4-Dinitrochlorobenzene induced Nc/Nga atopic dermatitis mice by non-thermal plasma , 2016, Scientific Reports.

[60]  D. Son,et al.  Differential Chemokine Signature between Human Preadipocytes and Adipocytes , 2016, Immune network.

[61]  P. Trayhurn,et al.  IL-1β (interleukin-1β) stimulates the production and release of multiple cytokines and chemokines by human preadipocytes , 2016, Archives of physiology and biochemistry.

[62]  M. Vacca,et al.  Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis. , 2016, Cardiovascular research.

[63]  A. Christiano,et al.  Functional interpretation of genome-wide association study evidence in alopecia areata , 2015, The Journal of investigative dermatology.

[64]  Bernhard T. Baune,et al.  Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders , 2015, Front. Cell. Neurosci..

[65]  Ilana Katz Sand,et al.  Classification, diagnosis, and differential diagnosis of multiple sclerosis , 2015 .

[66]  J. Skarbinski,et al.  Human immunodeficiency virus transmission at each step of the care continuum in the United States. , 2015, JAMA internal medicine.

[67]  F. Gao,et al.  Association of CCL13 Levels in Serum and Synovial Fluid With the Radiographic Severity of Knee Osteoarthritis , 2015, Journal of Investigative Medicine.

[68]  Ruslan Medzhitov,et al.  Homeostasis, Inflammation, and Disease Susceptibility , 2015, Cell.

[69]  J. Margolick,et al.  The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.

[70]  S. Clément,et al.  Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells. , 2015, Stem cells and development.

[71]  Paul Martin,et al.  Wound repair and regeneration: Mechanisms, signaling, and translation , 2014, Science Translational Medicine.

[72]  N. Wentzensen,et al.  Body Mass Index, Physical Activity, and Serum Markers of Inflammation, Immunity, and Insulin Resistance , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[73]  Connie Celum,et al.  HIV infection: epidemiology, pathogenesis, treatment, and prevention , 2014, The Lancet.

[74]  A. Pradeep,et al.  Crevicular and serum levels of monocyte chemoattractant protein-4 and high-sensitivity C-reactive protein in periodontal health and disease. , 2014, Archives of oral biology.

[75]  E. García-Zepeda,et al.  A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma. , 2014, International immunopharmacology.

[76]  J. Hohlfeld,et al.  Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics , 2014, BMC Immunology.

[77]  R. Townley,et al.  Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma , 2014, Expert opinion on biological therapy.

[78]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[79]  Hualiang Jiang,et al.  Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.

[80]  S. Mosesova,et al.  Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. , 2013, The Journal of allergy and clinical immunology.

[81]  Y. Takasaki,et al.  CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis , 2013, Modern rheumatology.

[82]  Xianwei Wang,et al.  Ox-LDL Promotes Migration and Adhesion of Bone Marrow-Derived Mesenchymal Stem Cells via Regulation of MCP-1 Expression , 2013, Mediators of inflammation.

[83]  E. García-Zepeda,et al.  The multiple faces of CCL13 in immunity and inflammation , 2013, Inflammopharmacology.

[84]  M. Wagenmann,et al.  Comparison of the Nasal Release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in Allergic Rhinitis during Season and after Allergen Challenge , 2013, American journal of rhinology & allergy.

[85]  L. Minthon,et al.  Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters , 2013, Psychoneuroendocrinology.

[86]  T. Roskams,et al.  Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. , 2013, Journal of hepatology.

[87]  A. Pradeep,et al.  Correlation of MCP-4 and high-sensitivity C-reactive protein as a marker of inflammation in obesity and chronic periodontitis. , 2013, Cytokine.

[88]  Y. Takasaki,et al.  Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis , 2012, Immunopharmacology and immunotoxicology.

[89]  Michael Landthaler,et al.  Cytokines, chemokines and growth factors in wound healing , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[90]  D. Wang,et al.  Expression profiles of regulatory and helper T‐cell‐associated genes in nasal polyposis , 2012, Allergy.

[91]  M. Sisto,et al.  Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB , 2012, Laboratory Investigation.

[92]  S. Twining,et al.  Thrombin Increases Human Corneal Fibroblast Expression Of The Chemokines, CXCL1, CCL2, IL-6, IL-8, CXCL10 And CCL13 , 2012 .

[93]  Lutz Claes,et al.  Fracture healing under healthy and inflammatory conditions , 2012, Nature Reviews Rheumatology.

[94]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[95]  M. Hatano,et al.  Bcl6 in pulmonary epithelium coordinately controls the expression of the CC‐type chemokine genes and attenuates allergic airway inflammation , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[96]  T. Gambichler,et al.  Serum CCL13 levels in patients with systemic sclerosis and controls , 2011, The British journal of dermatology.

[97]  J. Foulkes I. Introduction , 2010, New Surveys in the Classics.

[98]  L. Folkersen,et al.  Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. , 2010, Cardiovascular research.

[99]  E. Celius,et al.  Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis , 2010, Genes and Immunity.

[100]  M. Fujimoto,et al.  CCL13 is a promising diagnostic marker for systemic sclerosis , 2010, The British journal of dermatology.

[101]  I. Pavić,et al.  Immunologic aspects of atopic dermatitis. , 2009, Acta dermatovenerologica Croatica : ADC.

[102]  P. Heinrich,et al.  Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[103]  C. Rizzi,et al.  M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms1 , 2009, The Journal of Immunology.

[104]  O. Grip,et al.  Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease , 2009, PloS one.

[105]  I. Elovaara,et al.  Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression , 2009, Journal of Neuroimmunology.

[106]  L. Teran,et al.  Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma , 2008, European Respiratory Journal.

[107]  C. González-Bonilla,et al.  CDIP‐2, a synthetic peptide derived from chemokine (C‐C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation , 2008, Clinical and experimental immunology.

[108]  K. Ikari,et al.  A role of monocyte chemoattractant protein‐4 (MCP‐4)/CCL13 from chondrocytes in rheumatoid arthritis , 2007, The FEBS journal.

[109]  T. Nishimura,et al.  Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. , 2007, International journal of molecular medicine.

[110]  R. Pawankar,et al.  Expression of MCP-4 by TLR ligand-stimulated nasal polyp fibroblasts , 2007, Acta oto-laryngologica.

[111]  M. Pittelkow,et al.  Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications , 2007, Experimental dermatology.

[112]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[113]  H. Makino,et al.  Elevated Serum Monocyte Chemoattractant Protein‐4 and Chronic Inflammation in Overweight Subjects , 2006, Obesity.

[114]  M. Kaneko,et al.  A Novel, Selective, and Orally Available Antagonist for CC Chemokine Receptor 3 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[115]  S. Momohara,et al.  Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. , 2006, Rheumatology.

[116]  L. Teran,et al.  Role of the chemokines RANTES, monocyte chemotactic proteins‐3 and ‐4, and eotaxins‐1 and ‐2 in childhood asthma , 2003, European Respiratory Journal.

[117]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[118]  A. Diepstra,et al.  Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas , 2002, International journal of cancer.

[119]  D. Heresbach,et al.  Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis. , 2001, European cytokine network.

[120]  A. Howie,et al.  Potential role for monocyte chemotactic protein‐4 (MCP‐4) in monocyte/macrophage recruitment in acute renal inflammation , 2001, The Journal of pathology.

[121]  T. Karlsen,et al.  Primary sclerosing cholangitis , 2001, The Lancet.

[122]  J. Lafitte,et al.  Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.

[123]  L. Wagner,et al.  Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. , 2000, American journal of respiratory and critical care medicine.

[124]  G. Opdenakker,et al.  The MCP/eotaxin subfamily of CC chemokines. , 1999, Cytokine & growth factor reviews.

[125]  C. Schlüter,et al.  Genomic organization, sequence analysis and transcriptional regulation of the human MCP-4 chemokine gene (SCYA13) in dermal fibroblasts: a comparison to other eosinophilic beta-chemokines. , 1999, Biochemical and biophysical research communications.

[126]  A. Luster,et al.  Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation , 1997, Journal of leukocyte biology.

[127]  Q. Hamid,et al.  Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.

[128]  G. Lärfars,et al.  Letter of apology , 1996 .

[129]  J. Bogdanowicz,et al.  REPORT OF THREE CASES. , 1963, American journal of diseases of children.

[130]  Peng Zhang,et al.  Integrated analysis of hub gene expression in multiple myeloma. , 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[131]  Feng-hua Liu,et al.  A systematic analysis , 2020 .

[132]  I. Sora,et al.  Chemokine alterations in the postmortem brains of suicide completers. , 2019, Journal of psychiatric research.

[133]  J. Cavanagh,et al.  Neuroimmune Biomarkers in Mental Illness. , 2018, Current topics in behavioral neurosciences.

[134]  A. Ochiai,et al.  Site-specific fibroblasts regulate site-specific inflammatory niche formation in gastric cancer , 2015, Gastric Cancer.

[135]  Y. El-Gamal,et al.  Monocyte chemotactic protein-4 (MCP-4/CCL-13) and CC chemokine receptor 3 (CCR3) in the sputum of asthmatic children , 2007 .

[136]  Jie Li,et al.  Pathophysiology of acute wound healing. , 2007, Clinics in dermatology.

[137]  A. Brain Historical Aspects and Future Directions , 1998, International anesthesiology clinics.